Allogene Therapeutics News

Allogene Therapeutics | EFFECT: Others

Apr 26 06:09 ET

Allogene Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Apr 22 16:13 ET

Allogene Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 14 16:39 ET

Allogene Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Jan 22 00:00 ET

Allogene Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 18, 2023 16:17 ET

Allogene Therapeutics | 424B5: Prospectus

Nov 2, 2023 16:41 ET

Allogene Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Aug 7, 2023 17:15 ET

Allogene Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Jun 29, 2023 14:08 ET

Allogene Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Jun 20, 2023 16:37 ET

Allogene Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Jun 12, 2023 19:08 ET

Allogene Therapeutics | 424B5: Prospectus

Jun 3, 2020 16:14 ET

Allogene Therapeutics | 424B5: Prospectus

Jun 1, 2020 06:38 ET

Allogene Therapeutics | 424B4: Prospectus

Oct 11, 2018 17:24 ET

Allogene Therapeutics | EFFECT: Others

Oct 11, 2018 00:15 ET

Allogene Therapeutics | 8-A12B: Registration of a class of securities on a national securities exchange

Oct 5, 2018 17:07 ET